Stewart CF - Search Results

1

Cyclophosphamide disposition in an anephric child.

McCune JS, Adams D, Homans AC, Guillot A, Iacono L, Stewart CF. McCune JS, et al. Among authors: stewart cf. Pediatr Blood Cancer. 2006 Jan;46(1):99-104. doi: 10.1002/pbc.20558. Pediatr Blood Cancer. 2006. PMID: 16155930

2

Effect of hemodialysis on topotecan disposition in a patient with severe renal dysfunction.

Herrington JD, Figueroa JA, Kirstein MN, Zamboni WC, Stewart CF. Herrington JD, et al. Among authors: stewart cf. Cancer Chemother Pharmacol. 2001;47(1):89-93. doi: 10.1007/s002800000224. Cancer Chemother Pharmacol. 2001. PMID: 11221968

3

Determination of plasma topotecan and its metabolite N-desmethyl topotecan as both lactone and total form by reversed-phase liquid chromatography with fluorescence detection.

Bai F, Kirstein MN, Hanna SK, Iacono LC, Johnston B, Stewart CF. Bai F, et al. Among authors: stewart cf. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Feb 5;784(2):225-32. doi: 10.1016/s1570-0232(02)00798-5. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 12505770

4

The importance of pharmacokinetic limited sampling models for childhood cancer drug development.

Panetta JC, Iacono LC, Adamson PC, Stewart CF. Panetta JC, et al. Among authors: stewart cf. Clin Cancer Res. 2003 Nov 1;9(14):5068-77. Clin Cancer Res. 2003. PMID: 14613983 Review.

5

Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors.

Wagner LM, Crews KR, Iacono LC, Houghton PJ, Fuller CE, McCarville MB, Goldsby RE, Albritton K, Stewart CF, Santana VM. Wagner LM, et al. Among authors: stewart cf. Clin Cancer Res. 2004 Feb 1;10(3):840-8. doi: 10.1158/1078-0432.ccr-03-0175. Clin Cancer Res. 2004. PMID: 14871959 Clinical Trial.

6

Phase I and pharmacokinetic study of topotecan administered orally once daily for 5 days for 2 consecutive weeks to pediatric patients with refractory solid tumors.

Daw NC, Santana VM, Iacono LC, Furman WL, Hawkins DR, Houghton PJ, Panetta JC, Gajjar AJ, Stewart CF. Daw NC, et al. Among authors: stewart cf. J Clin Oncol. 2004 Mar 1;22(5):829-37. doi: 10.1200/JCO.2004.07.110. J Clin Oncol. 2004. PMID: 14990638 Clinical Trial.

7

Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumor.

Stewart CF, Iacono LC, Chintagumpala M, Kellie SJ, Ashley D, Zamboni WC, Kirstein MN, Fouladi M, Seele LG, Wallace D, Houghton PJ, Gajjar A. Stewart CF, et al. J Clin Oncol. 2004 Aug 15;22(16):3357-65. doi: 10.1200/JCO.2004.10.103. J Clin Oncol. 2004. PMID: 15310781 Clinical Trial.

8

Topoisomerase I interactive agents.

Turner PK, Iacono LC, Stewart CF. Turner PK, et al. Among authors: stewart cf. Cancer Chemother Biol Response Modif. 2003;21:69-101. doi: 10.1016/s0921-4410(03)21004-8. Cancer Chemother Biol Response Modif. 2003. PMID: 15338741 Review.

9

Topotecan disposition in an anephric child.

Iacono LC, Adams D, Homans AC, Guillot A, McCune JS, Stewart CF. Iacono LC, et al. Among authors: stewart cf. J Pediatr Hematol Oncol. 2004 Sep;26(9):596-600. doi: 10.1097/01.mph.0000137368.27242.ca. J Pediatr Hematol Oncol. 2004. PMID: 15342988

10

Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).

Broniscer A, Iacono L, Chintagumpala M, Fouladi M, Wallace D, Bowers DC, Stewart C, Krasin MJ, Gajjar A. Broniscer A, et al. Cancer. 2005 Jan 1;103(1):133-9. doi: 10.1002/cncr.20741. Cancer. 2005. PMID: 15565574 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

322 results

Search Page